Abstract
Type 1 diabetes is an autoimmune disease resulting in the loss of insulin production and, consequently, hyperglycemia. The nonobese diabetic (NOD) mouse develops spontaneous diabetes with considerable similarity to the disease in humans. Immunological studies using the NOD mouse model allow for the investigation of the natural history of the disease and leukocyte and lymphocyte pathogenic and regulatory functions, as well as testing potential therapies for intervention. The analyses of the cellular events leading up to diabetes may utilize different in vitro cellular assays, immunohistochemistry, and in vivo adoptive transfer, to study mechanisms of the disease and the effects of therapeutic intervention. In this chapter, we describe some common techniques for phenotyping and mechanistic analyses of function, particularly of CD8+ T cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thayer TC, Wilson SB, Mathews CE (2010) Use of nonobese diabetic mice to understand human type 1 diabetes. Endocrinol Metab Clin N Am 39(3):541–561. https://doi.org/10.1016/j.ecl.2010.05.001
Chaparro RJ, Dilorenzo TP (2010) An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol 6(6):939–955. https://doi.org/10.1586/eci.10.68
Pearson JA, Wong FS, Wen L (2016) The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun 66:76–88. https://doi.org/10.1016/j.jaut.2015.08.019
Lehuen A, Diana J, Zaccone P, Cooke A (2010) Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 10(7):501–513. https://doi.org/10.1038/nri2787
Raphael I, Nalawade S, Eagar TN, Forsthuber TG (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74(1):5–17. https://doi.org/10.1016/j.cyto.2014.09.011
Pearson JA, Wong FS (2016) Identification of islet antigen-specific CD8 T cells using MHCI-peptide tetramer reagents in the non obese diabetic (NOD) mouse model of type 1 diabetes. Methods Mol Biol 1433:119–125. https://doi.org/10.1007/7651_2015_295
Thayer TC, Wong FS (2016) Tracking immunological responses of islet antigen-specific T cells in the nonobese diabetic (NOD) mouse model of type 1 diabetes. Methods Mol Biol 1433:127–134. https://doi.org/10.1007/7651_2015_293
Höppner M, Luhm J, Schlenke P, Koritke P, Frohn C (2002) A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J Immunol Methods 267(2):157–163
Wong FS, Siew LK, Scott G, Thomas IJ, Chapman S, Viret C, Wen L (2009) Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes. Diabetes 58(5):1156–1164. https://doi.org/10.2337/db08-0800
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Thayer, T.C., Kakabadse, D., Boldison, J., Wong, F.S. (2020). Assessing Immune Responses in the Nonobese Diabetic Mouse Model of Type 1 Diabetes. In: King, A. (eds) Animal Models of Diabetes. Methods in Molecular Biology, vol 2128. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0385-7_18
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0385-7_18
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0384-0
Online ISBN: 978-1-0716-0385-7
eBook Packages: Springer Protocols